Amytal Sodium (Valeant Pharmaceuticals North America LLC)
Welcome to the PulseAid listing for the Amytal Sodium drug offered from Valeant Pharmaceuticals North America LLC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Valeant Pharmaceuticals North America LLC |
| NON-PROPRIETARY NAME: | amobarbital sodium |
| SUBSTANCE NAME: | AMOBARBITAL SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAMUSCULAR; INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2008-09-25 |
| END MARKETING DATE: | 0000-00-00 |
Amytal Sodium HUMAN PRESCRIPTION DRUG Details:
| Item Description | Amytal Sodium from Valeant Pharmaceuticals North America LLC |
| LABELER NAME: | Valeant Pharmaceuticals North America LLC |
| DEA SCHEDULE: | CII
|
| ACTIVE STRENGTH: | 0.5(g/5mL) |
| START MARKETING DATE: | 2008-09-25 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0187-4303_94ba4d57-e4da-4080-9c8e-9e0065aef659 |
| PRODUCT NDC: | 0187-4303 |
| APPLICATION NUMBER: | |
Other AMOBARBITAL SODIUM Pharmaceutical Manufacturers / Labelers:
